Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 27.40
-1.44 (-4.99%)
Sep 11, 2026, 4:08 PM HKT
HKG:3378 Market Cap
HKG:3378 has a market cap or net worth of 3.73 billion as of September 11, 2026.
Market Cap
3.73B
Enterprise Value
3.25B
Revenue
84.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
27.40
ChartMarket Cap Chart
Since December 23, 2025, HKG:3378's market cap has increased from 2.34B to 3.73B, an increase of 59.30%. That is a compound annual growth rate of 91.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.73B | 71.46% |
| Dec 31, 2025 | 2.18B | -7.09% |
| Dec 23, 2025 | 2.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 5.15B |
| Jacobio Pharmaceuticals Group | 4.80B |
| Ocumension Therapeutics | 4.37B |
| TransThera Sciences (Nanjing) | 3.83B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.65B |
| HJ Science | 3.14B |
| Jiangsu Recbio Technology | 3.08B |